SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001516551-22-000016
Filing Date
2022-06-17
Accepted
2022-06-17 17:22:30
Documents
14
Period of Report
2022-06-14
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 4.01: Changes in Registrant's Certifying Accountant
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K skye-20220614.htm   iXBRL 8-K 54414
2 EX-10.1 projectfran-amendmentno1to.htm EX-10.1 30296
3 EX-16.1 skye8kletterofmhmtosec.htm EX-16.1 2816
  Complete submission text file 0001516551-22-000016.txt   226232

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT skye-20220614.xsd EX-101.SCH 1921
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT skye-20220614_lab.xml EX-101.LAB 22080
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT skye-20220614_pre.xml EX-101.PRE 11526
8 EXTRACTED XBRL INSTANCE DOCUMENT skye-20220614_htm.xml XML 10674
Mailing Address 11250 EL CAMINO REAL, SUITE 100 SAN DIEGO CA 92130
Business Address 11250 EL CAMINO REAL, SUITE 100 SAN DIEGO CA 92130 (858) 410-0266
Skye Bioscience, Inc. (Filer) CIK: 0001516551 (see all company filings)

IRS No.: 450692882 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-55136 | Film No.: 221025128
SIC: 2834 Pharmaceutical Preparations